Repositioning approved drugs for the treatment of problematic cancers using a screening approach.
Advances in treatment strategies together with an earlier diagnosis have considerably increased the average survival of cancer patients over the last four decades. Nevertheless, despite the growing number of new antineoplastic agents introduced each year, there is still no adequate therapy for probl...
Saved in:
| Main Authors: | Hristo P Varbanov, Fabien Kuttler, Damiano Banfi, Gerardo Turcatti, Paul J Dyson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171052&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Silico Study of FDA-Approved Drugs on <i>Leishmania infantum</i> CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis
by: Juan Diego Guarimata, et al.
Published: (2024-11-01) -
A Search for FDA Approved Drugs with Multiple Antiemetic Targets: A Computational-Based Drug Repositioning Study
by: Abdulmajeed Yunusa*1, Albashir Tahir1,2
Published: (2025-05-01) -
A Search for FDA Approved Drugs with Anti-ulcerative Effects: A computational Based Drug Repositioning Study
by: Abdulmajeed Yunusa1, Albashir Tahir1,2, Nura Abubakar1
Published: (2025-05-01) -
Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in <i>Trypanosoma cruzi</i>: Virtual Screening and In Vitro Studies
by: Eyra Ortiz-Pérez, et al.
Published: (2025-05-01) -
Identification of glutathione transferase (GST P1) inhibitors via a high-throughput screening assay and implications as alternative treatment options for breast cancers
by: Sarah A. P. Pereira, et al.
Published: (2025-01-01)